Corbus Pharmaceuticals Holdings, Inc. (CRBP) short interest & options flow
NASDAQCorbus Pharmaceuticals just delivered a notable week: Q1 earnings arrived, the stock rallied more than 7%, and every analyst on the name trimmed their target anyway. That tension — a price climbing while Street estimates come down — is the defining story heading into the next leg of the CRBP trade. The Earnings Print The Q1 results landed on May 12. EPS came in…
CRBP cost to borrow surges 206% in one week to 0.49%, driven by tightening share availability as short interest rises 7.3% to 7.3% of float.
- Market cap
- $83M
- Next earnings
- 16 Nov 2026
Key data as of 12 Nov 2026
Latest signals on CRBP
- Cost to Borrow
CRBP cost to borrow surges 206% in one week to 0.49%, driven by tightening share availability as short interest rises 7.3% to 7.3% of float.
CRBP news and analysis
RSSNo long-form analysis yet for CRBP. Pulse alerts and the live data picture are available on ORTEX.
Open CRBP on ORTEX →Want the live picture for CRBP?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRBP — free to start on ORTEX.
Sign up for free →Open CRBP on ORTEX